MAINE MOLECULAR QUALITY CONTROLS INC

Maine Molecular Quality Controls Inc. specializes in the development and production of molecular quality control materials used in clinical and research laboratories to ensure the accuracy and reliability of diagnostic testing. The company’s core capabilities center on the formulation, validation, and manufacturing of stable, traceable molecular controls for PCR, next-generation sequencing, and other nucleic acid-based assays. Their technical expertise includes precision aliquoting, lyophilization, cold chain logistics, and ISO 13485-compliant production processes, with a focus on supporting clinical laboratories in maintaining regulatory compliance and analytical integrity. A key differentiator is their commitment to matrix-matched controls that replicate real patient samples, enhancing test performance monitoring across diverse diagnostic platforms. Award history is not available to confirm specific agency engagements, so no definitive patterns of federal partnership can be inferred. However, given the nature of their products, their materials are likely utilized by laboratories under the CDC, FDA, NIH, and military healthcare systems where molecular diagnostics are critical to public health surveillance and clinical decision-making. The company operates primarily within NAICS 325413, which encompasses the manufacturing of in vitro diagnostic substances. In practice, this means they produce reference materials and controls essential for validating diagnostic assays used in infectious disease testing, genetic screening, and personalized medicine. Their market positioning is that of a niche, high-precision supplier serving the growing demand for standardized quality assurance tools in molecular diagnostics. As a Women-Owned Small Business and Woman-Owned Business certified entity, Maine Molecular Quality Controls Inc. is strategically positioned within the federal small business procurement landscape. Located in Saco, Maine, the company maintains a focused, facility-based manufacturing operation with an emphasis on regulatory compliance and scientific rigor rather than broad-scale distribution.